Trailing-twelve-month (TTM) revenue is $1.82 Billion with a year-over-year growth of (2.45%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-08-31 | $431,781,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-09 |
| Q3 FY2026Period ended 2025-11-30 | $512,829,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-08 |
| Q4 FY2026Period ended 2026-02-28 | $470,025,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-23 |
| Q1 FY2027Period ended 2026-05-31 | $402,115,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-08 |
| TTM revenue | $1,816,750,000 |
Current P/S: $589,754,985 market capitalization ÷ $1,816,750,000 TTM revenue = 0.32x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-05-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-05-31): $402.12M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:46:48.691Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-02-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-02-28 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-02-29 · USD | FY20212021-02-28 · USD | FY20222022-02-28 · USD | FY20232023-02-28 · USD | FY20242024-02-29 · USD | FY20252025-02-28 · USD |
|---|---|---|---|---|---|---|
| Beauty & Wellness | N/A | N/A | N/A | $1.2B | $1.1B | $1.0B |
| Beauty Segment | $381M | $481M | $580M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-02-28 · USD | FY20222022-02-28 · USD | FY20232023-02-28 · USD | FY20242024-02-29 · USD | FY20252025-02-28 · USD | FY20262026-02-28 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $118M | $110M | $116M | $116M | $125M | $107M |
| CANADA | $92M | $102M | $108M | $82M |
$1.82B
$1.82 Billion
(2.45%)
vs. $1.86B a year ago (TTM)
(3.92%)
5 Year compound annual growth rate
1 Year
(2.45%)
3 Year
(3.78%)
5 Year
(3.92%)
10 Year
+1.61%
15 Year
+4.88%
20 Year
+5.76%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $1.79B | ($121.38M) | (6.36%) |
| 2025 | $1.91B | ($97.39M) | (4.86%) |
| 2024 | $2.01B | ($67.62M) | (3.26%) |
| 2023 | $2.07B | ($150.69M) | (6.78%) |
| 2022 | $2.22B | +$124.56M | +5.93% |
| 2021 |
TTM Growth
(2.45%)
3-Year CAGR
(3.78%)
5-Year CAGR
(3.92%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T20:46:48.691Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Health & Wellness | N/A | N/A | $777M | N/A | N/A | N/A |
|---|
| Healthcare Home Environment | $685M | $890M | N/A | N/A | N/A | N/A |
|---|
| Home & Outdoor | N/A | N/A | $866M | $916M | $916M | $906M |
|---|
| Housewares | $641M | $727M | N/A | N/A | N/A | N/A |
|---|
| $74M |
| EMEA | $183M | $215M | $268M | $284M | $295M | $293M |
|---|
| Latin America | $39M | $59M | $42M | $44M | $48M | $34M |
|---|
| UNITED STATES | $1.7B | $1.7B | $1.5B | $1.5B | $1.4B | $1.3B |
|---|
| $2.10B |
| +$391.37M |
| +22.92% |
| 2020 | $1.71B | +$143.28M | +9.16% |
| 2019 | $1.56B | +$85.31M | +5.77% |
| 2018 | $1.48B | +$81.31M | +5.82% |
| 2017 | $1.40B | +$4.96M | +0.36% |
